domingo, 5 de marzo de 2017

Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing. - PubMed - NCBI

Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing. - PubMed - NCBI



 2017 Mar;18(4):359-367. doi: 10.2217/pgs-2016-0177. Epub 2017 Feb 22.

Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.

Abstract

AIM:

To investigate provider utilization of pharmacist support in the delivery of pharmacogenetic testing in a primary care setting.

METHODS:

Two primary care clinics within Duke University Health System participated in the study between December 2012 and July 2013. One clinic was provided with an in-house pharmacist and the second clinic had an on-call pharmacist.

RESULTS:

Providers in the in-house pharmacist arm consulted with the pharmacist for 13 of 15 cases, or about one of every four patients tested compared with one of every 7.5 patients in the on-call pharmacist arm. A total of 63 tests were ordered, 48 by providers in the pharmacist-in-house arm.

CONCLUSION:

These findings suggest that the availability of an in-house pharmacist increases the likelihood of pharmacogenetic test utilization.

KEYWORDS:

delivery model; education; pharmacist consultation; pharmacogenetic testing

PMID:
 
28244812
 
DOI:
 
10.2217/pgs-2016-0177

[PubMed - in process]